Individualized, Additively Manufactured Drug-Releasing External Ear Canal Implant for Prevention of Postoperative Restenosis: Development, In Vitro Testing, and Proof of Concept in an Individual Curative Trial

Postoperative restenosis in patients with external ear canal (EEC) atresia or stenosis is a common complication following canaloplasty. Our aim in this study was to explore the feasibility of using a three dimensionally (3D)-printed, patient-individualized, drug ((dexamethasone (DEX)), and ciproflox...

Descripción completa

Detalles Bibliográficos
Autores principales: Matin-Mann, Farnaz, Gao, Ziwen, Schwieger, Jana, Ulbricht, Martin, Domsta, Vanessa, Senekowitsch, Stefan, Weitschies, Werner, Seidlitz, Anne, Doll, Katharina, Stiesch, Meike, Lenarz, Thomas, Scheper, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228097/
https://www.ncbi.nlm.nih.gov/pubmed/35745813
http://dx.doi.org/10.3390/pharmaceutics14061242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228097/
https://www.ncbi.nlm.nih.gov/pubmed/35745813
http://dx.doi.org/10.3390/pharmaceutics14061242

Ejemplares similares